Article

LAG-3 and PD-1/PD-L1 inhibitors might become a promising treatment for small cell lung cancer

2020-08-18

Abstract excerpt

<title>Abstract</title> <p><bold>Background </bold>Immune therapy has achieved notable success in cancer treatment. A novel immunocheckpoint, Lymphocyte activing gene-3 (LAG-3), has shown promising therapeutic efficacy in non-small cell lung cancer (NSCLC). However, literature about LAG-3 in small cell lung cancer (SCLC) is scarce. We performed statistical analysis to explore LAG-3 expression in SCLC patients, th...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 3225d711-915b-54b7-8cfe-31107adb6ab4
DOI: 10.21203/rs.3.rs-48482/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

LAG-3 and PD-1/PD-L1 inhibitors might become a promising treatment for small cell lung cancerDOI 10.21203/rs.3.rs-48482/v1Read

LAG-3 and PD-1/PD-L1 Inhibitors Might Become a Promising Treatment for Small Cell Lung CancerSemantic proximity Read

Lymphocyte‐activation gene‐3, an important immune checkpoint in cancerSemantic proximity Read

LAG-3 Protein Expression in Non-Small Cell Lung Cancer and Its Relationship with PD-1/PD-L1 and Tumor-Infiltrating Lymphocytes.Semantic proximity Read

Lymphocyte-activation gene 3 in cancer immunotherapy: function, prognostic biomarker and therapeutic potentialsSemantic proximity Read

Epidermal growth factor receptor tyrosine kinase inhibitor remodels tumor microenvironment by upregulating LAG-3 in advanced non-small-cell lung cancer.Semantic proximity Read

Coexpression of LAG-3 and PD-L1 in tumor infiltrating immune cells predicts worse outcome in clear cell renal cell carcinomaSemantic proximity Read

LAG-3: from molecular functions to clinical applicationsSemantic proximity Read

Prognostic value of delta‑like protein 3 combined with thyroid transcription factor‑1 in small‑cell lung cancerSemantic proximity Read

Gene of the month: lymphocyte-activation gene 3 (LAG-3)Semantic proximity Read

Lymphocyte activating gene 3 protein expression in nasopharyngeal carcinoma is correlated with programmed cell death-1 and programmed cell death ligand-1, tumor-infiltrating lymphocytesSemantic proximity Read

Understanding LAG-3 SignalingSemantic proximity Read

Identification of inflamed-phenotype of small cell lung cancer leading to the efficacy of anti-PD-L1 antibody and chemotherapy.Semantic proximity Read